Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-14

Clinical Trial Update: Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for glycopyrronium in axillary hyperhidrosis has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • glycopyrronium (glycopyrronium)

Snippet

Sponsor: Journey Medical Corporation | Conditions: Hyperhidrosis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-14